Spelling suggestions: "subject:"mucus"" "subject:"fucus""
81 |
Gelace mucinu – příprava artificiálních modelů pro studium biologických mukózních systémů / Mucin hydrogels - artificial models of native mucus systemsMikušová, Janka January 2021 (has links)
The scope of this masters thesis is the preparation of a model mucin system and its utilization as an artificial model of the native mucus system. The creation of this model system, according to several designed methods was a part of experimental part of the thesis. The preparation of mucin system comprised of physical and chemical methods of hydrogel formation, screening and characterisation of the various physical conditions of the mucin properties on its molecular level, and the preparation of sorbent with sorption surface containing mucin. Methods of light scattering, namely dynamic light scattering (DLS), used for mucin particles size change monitoring, and electroforetic light scattering (ELS), used for Zeta potential change monitoring, were used for the screening of the impact of physical factors on the properties of mucin.For the characterisation of impact of the temperature on changes in mucin sctructure was, apart from monitoring of light scattering, used also a diferential scanning calorimetry (DSC), which registered temperature value, at which mucin thermal denaturation occurs. In the next part of the thesis we subdued the created sorption surfaces to various physical-chemical analyses, which task is the characterisation and projection of surface and confirmation of mucin presence.Substancial part in monitoring and characterisation of changes in surface sctructure of sorption surface was accomplished by Fourier transform infrared spectroscopy (FTIR). Scanning electron microscophy (SEM) was used for the final, more detailed, projection of the mucin enriched, sorbent surface structure. Suggested methods of mucin hydrogel, didnt prove sufficient results for the possibility of application of hydrogel as a artificial model of real mucus system, but the sorbent application was indicated as a suitable alternative and an instrument for the further mucin behaviour research and possibly subsequent bacterial adhesion, which represents the first step in the formation of the bacterial biofilm.
|
82 |
Studies in Applied Materials Science: Drug-Biofluid Interactions and Light-Emitting Polymer FilmsCornell, Ashley Lynn 12 May 2012 (has links)
Interactions of Asthma Drugs with Artificial Saliva and Mucus. Modeling pulmonary particulate transport requires related biofluid physicochemical properties. Aims included measuring the effects of common aerosol drugs on artificial saliva and diffusivities of asthma medications in mucus. Artificial saliva solutions doped with asthma medications were characterized by pH, interfacial tension, and rheology. To measure diffusion, drug concentration was monitored by time-dependent FTIR spectra, and diffusivity obtained using Fick¡¦s second law. Measured theophylline and albuterol diffusivities were ca. 10-6 cm2/s. Surface Modification of Polymer Films with Light-Emitting Chemicals. To develop a polymer film system that changed color in response to radiation, acid groups of poly(ethylene-co-acrylic acid) were used to attach two light-emitting polymers: 4„S-(octyloxy)-4-biphenylcarboxylic acid and 2,7-bis(bromomethyl)-9,9-dihexyl-9Hluorene. Each reaction step was confirmed using static contact angle goniometry, FTIR spectroscopy, and X-ray photoelectron spectroscopy. UV-Vis and fluorescence spectroscopy measured the absorption spectra. Modified films were irradiated (ƒÜ=254 nm) and produced blue emissions.
|
83 |
Modeling the Mechanical Effects of Liquid Mediated Adhesion Between the Human Vocal FoldsDecker, Gifford Zach 19 July 2006 (has links) (PDF)
The vocal folds are a complex self-oscillating biological system. In the current research, an equation was developed to model viscous adhesion forces that occur when the collision of the vocal folds results in the formation of a liquid bridge. The adhesion equation was validated using experimental data, and simplified to a one-dimensional approximation with an included correction factor that adjusted the predicted pressure in situations where the one-dimensional approximation was invalid. A non-oscillating vocal fold model with a modeled liquid bridge was used to study stress resulting from viscous adhesion. The vertical normal stress magnitude ranged from about 80 to 1700 Pa. This was shown to be of the same order of magnitude as the stress due to collision of the vocal folds. Also the stress resulted in large normal strains that occurred at small distances below the surface of the vocal folds consistent with lesion development. Therefore, it was determined that the viscous adhesion may be a contributor to damage of the vocal folds that leads to the development of benign lesions, such as vocal nodules. This conclusion was further validated by adding the adhesion equation in a self-oscillating vocal fold model. The influence of adhesion on the dynamics of the model was significant. The frequency of vibration was reduced by nearly 2.5% for the case of adhesion with a mucus viscosity of 0.01 Pa-s. Also adhesion induced positive tensile stress that resulted in normal strain distributions similar to those seen in the non-oscillating cases. These results also indicated that liquid mediated viscous adhesion may be a contributor to the development of benign lesions (nodules). However, further research is needed to validate these conclusions.
|
84 |
Investigating mucin interactions with diverse surfaces for biomedical applicationsPetrou, Georgia January 2019 (has links)
Mucous membranes are covered with mucus, a viscoelastic hydrogel that plays an essential role in their protection from shear and pathogens. The viscoelasticity of mucus is owing to mucins, a group of densely glycosylated proteins. Mucins can interact with a wide range of surfaces; thus, there is big interest in exploring and manipulating such interactions for biomedical applications. This thesis presents investigations of mucin interactions with hydrophobic surfaces in order to identify the key features of mucin lubricity, as well as describes the development of materials that are optimized to interact with mucins. In Paper I we investigated the domains which make mucins outstanding boundary lubricants. The results showed that the hydrophobic terminal domains of mucins play a crucial role in the adsorption and lubrication on hydrophobic surfaces. Specifically, protease digestion of porcine gastric mucins and salivary mucins resulted in the cleavage of these domains and the loss of lubricity and surface adsorption. However, a “rescue” strategy was successfully carried out by grafting hydrophobic phenyl groups to the digested mucins and enhancing their lubricity. This strategy also enhanced the lubricity of polymers which are otherwise bad lubricants. In Paper II we developed mucoadhesive materials based on genetically engineered partial spider silk proteins. The partial spider silk protein 4RepCT was successfully functionalized with six lysines (pLys-4RepCT), or the Human Galectin-3 Carbohydrate Recognition Domain (hGal3-4RepCT). These strategies were aiming to either non-specific electrostatic interactions between the positive lysines and the negative mucins, or specific binding between the hGal3 and the mucin glycans. Coatings, fibers, meshes and foams were prepared from the new silk proteins, and the adsorption of porcine gastric mucins and bovine submaxillary mucins was measured, demonstrating enhanced adsorption. The work presented demonstrates how mucin-material interactions can provide us with valuable information for the development of new biomaterials. Specifically, mucin-based and mucin-inspired lubricants could provide desired lubrication to a wide range of surfaces, while our new silk based materials could be valuable tools for the development of mucosal dressings. / Slemhinnor täckts av slem, en viskoelastisk hydrogel som spelar en viktig roll för att skydda mot mekanisk nötning och patogener. Muciner, en grupp av tätt glykosylerade proteiner, spelar en viktig roll i viskoelasticiteten av slem. Eftersom muciner kan interagera med diverse ytor är det av stort intresse att utforska och manipulera sådana interaktioner för biomedicinska tillämpningar. Denna avhandling presenterar undersökningar av mucininteraktioner med hydrofoba ytor för att identifiera de viktigaste egenskaperna hos mucinsmörjning, samt beskriver utveckling av material som optimerades för att interagera med muciner. I Artikel I undersökte vi de domäner som bidrar till mucinernas enastående kapacitet som smörjmedel. Resultaten visade att mucinernas hydrofoba terminaldomäner spelar en avgörande roll vid adsorption och smörjning på hydrofoba ytor. Mer specifikt, proteasklyvning av svinmagemuciner och salivmuciner resulterade i klyvningen av dessa domäner och förlust av smörjning och ytadsorption. Genom att länka hydrofobiska fenylgrupper till de uppbrutna mucinerna, lyckades deras smörjningsegenskaper förbättras. Denna strategi förbättrade också smörjningsegenskaper hos andra polymerer som annars har dåliga smörjningsegenskaper. I Artikel II utvecklade vi mukoadhesiva material baserade på genetiskt modifierade partiella spindelsilkeproteiner. Spindelsilkeproteinet 4RepCT funktionaliserades framgångsrikt med tillsats av sex lysiner (pLys-4RepCT), eller den mänskliga Galectin-3 karbohydrat igenkänningsdomänen (hGal3-4RepCT). Syftet med dessa strategier var antingen att öka ospecifika elektrostatiska interaktioner mellan de positiva lysinerna och de negativa mucinerna, eller den specifika bindningen mellan hGal3 och mucin-glykanerna. Beläggningar, fibrer, nät och skum framställdes från de nya silkeproteinerna. Efter att adsorption av svinmagsmuciner och bovina submaxillära muciner uppmätts, visade de nya silkeproteinerna förbättrad mucin adsorption. Detta arbete visar hur interaktioner mellan mucin-material kan bidra med värdefull information för utvecklingen av nya biomaterial. Mucinbaserade och mucininspirerade smörjmedel kan ge önskad smörjning till ett brett spektrum av ytor, medan vår nya silkesbaserad material kan vara ett värdefullt verktyg för utvecklingen av slemhinneförband. / <p>QC 20190412</p>
|
85 |
Conséquences d'un stress chronique sur la barrière de mucus intestinal chez le rat : effet du probiotique Lactobacillus farciminis / Consequences of a chronic stress on intestinal mucus barrier in rat : effect of a probiotic Lactobacillus farciminisDa Silva, Stéphanie 07 November 2013 (has links)
Si les modifications dans l’expression et les propriétés des mucines ont été largement décrites dans la physiopathologie des maladies inflammatoires chroniques de l’intestin, la caractérisation structurale et fonctionnelle de la barrière de mucus reste parcellaire dans le contexte micro-inflammatoire du syndrome de l’intestin irritable (SII). Par ailleurs, certains traitements probiotiques préviennent la rupture de l’intégrité de la barrière épithéliale intestinale, provoquée en conditions de stress mais peu de travaux décrivent leur influence sur les modifications de la structure du mucus, induites par le stress. Cette étude a comme objectifs d’évaluer chez le rat (i) si un stress chronique modifie le nombre de cellules à mucus et l’expression de la mucine Muc2, ainsi que la nature biochimique des mucines secrétées au niveau de l’iléon et du côlon, et plus particulièrement les O-glycanes, (ii) si un traitement probiotique (Lactobacillus farciminis) prévient les modifications du mucus potentiellement induites, (iii) si les effets observés sont en lien avec la capacité de colonisation in vivo de L. farciminis.Méthodes. Des rats Wistar mâles ont reçu L. farciminis ou une solution saline. Les animaux ont été soumis au stress d’évitement passif de l’eau (WAS) pendant 1h/jour ou à un stress fictif (contrôle), pendant les 4 derniers jours des traitements. Différents prélèvements ont été effectués au niveau de l’iléon et du côlon pour (i) des analyses sur coupes (immuno-marquage, nombre de cellules à mucus) et (ii) la détermination du profil de O-glycosylation des mucines. La morphologie de la couche de mucus a été évaluée par microscopie à force atomique (AFM). L. farciminis a été visualisé par "Fluorescence in situ Hybridization", confirmée par qPCR et son adhésion à la muqueuse a été déterminée par une méthode ex situ. La perméabilité paracellulaire et la sensibilité viscérale ont été évaluées.Résultats. Le WAS ne modifie pas le nombre de cellules à mucus ni l’expression de la mucine Muc2 aux niveaux iléal et colique. L’analyse par spectrométrie de masse a révélé que le stress induit des altérations de la O-glycosylation des mucines. Une augmentation marquée du degré de complexité des structures glycaniques a été observée, se traduisant par l’apparition de chaînes polylactosaminiques, sans modification toutefois du taux de sialylation et de sulfatation des mucines. La couche de mucus en condition de stress, observée par AFM, présente une morphologie aplatie et moins cohésive. L'hypothèse serait que les modifications structurales des O-glycanes influencent les interactions physico-chimiques entre les fibres de mucines, impactant de manière négative l’intégrité de la barrière de mucus. Cette altération de la couche de mucus s'accompagne d'un défaut de la barrière épithéliale et d'une hypersensibilité viscérale. L’administration de la souche probiotique prévient ces changements provoqués par le WAS. L. farciminis a été retrouvé au sein de l’iléon et du côlon. Par ailleurs, la présence de "Segmented Filamentous Bacteria" (SFB) a été mise en évidence, par FISH et microscopie électronique, au niveau de l’iléon sur l'ensemble des animaux testés. Le traitement par L. farciminis induit une diminution de la population des SFB aussi bien chez les animaux contrôles que stressés. Conclusion. Nous avons montré qu’un stress chronique chez le rat, outre les modifications fonctionnelles de l'épithélium intestinal (hyperperméabilité intestinale et hypersensibilité viscérale), altère la structure O-glycanique des mucines sans affecter l’expression de Muc2. Ces altérations se traduisent par une perte des propriétés cohésives de la couche de mucus. La souche probiotique L. farciminis, en prévenant l’ensemble des modifications induites par le stress, contribue au renforcement de la fonction barrière de l'intestin. Cette étude fournit un argumentaire complémentaire pour l’utilisation de cette souche dans le traitement du SII. / Background. Despite a large body of literature incriminating mucus alterations in the pathogenesis of Intestinal Bowel Diseases (IBD), structural and physical changes in the mucus layer remain poorly understood in the micro-inflammatory context of Irritable Bowel Syndrome (IBS). Moreover, some probiotic treatments prevent stress-induced intestinal epithelial barrier impairment but little is known about their influence on intestinal mucin structural modifications and mucus properties induced by stress. Thereby, this study aimed at evaluating whether (i) a chronic stress modified the number of gut goblet cells and Muc2 expression, nature of secreted mucins in both ileum and colon and more particularly mucin O-glycosylation, (ii) L. farciminis treatment prevented these alterations and (iii) observed effects were related to the in vivo colonization capacity of L. farciminis.Methods. Wistar rats received orally L. farciminis (1011 UFC/day) or vehicle (NaCl 0.9% (w/v)) for 14 days. From day 10 to day 14, they were submitted either to sham (control) or 4-day Water Avoidance Stress (WAS) during 1 hour per day. After sacrifice, different samples (tissues, mucosa) were collected in both ileal and colonic regions for (i) histological analyses (Muc 2 immunohistochemistry, number of goblet cells by Periodic Acid Schiff/Hemalun) and (ii) O-glycosylation profile by mass spectrometry after mucin extraction and purification. In parallel, the morphology of the mucus layer was evaluated by atomic force microscopy. Spatial localization of L. farciminis was assessed by Fluorescence In Situ Hybridization (FISH), confirmed by qPCR. Mucosal adhesion of L. farciminis was determined by an ex situ method. In complement, intestinal paracellular permeability and visceral sensitivity were measured.Results. WAS did not modify neither the number of intestinal goblet cells nor Muc2 expression in both ileum and colon. In contrast, the mass spectrometry analysis demonstrated that O-glycosylation of mucins was strongly affected by WAS. Indeed, a strongly increase in the complexity degree of O-glycan structures was observed in both ileum and colon, with the appearance of elongated polylactosaminic chains (repetition of the disaccharidic unit composed of galactose and N-acetylglucosamine), without modifications of mucin sialylation and sulfation. Under stress conditions, the mucus layer, observed by atomic force microscopy, showed a flattened morphology, probably indicative of a loss in its cohesive properties. We hypothesized that O-glycan structural modifications influence physico-chemical interactions between mucins fibers. Stress also induced intestinal hyperpermeability and visceral hypersensitivity. The mucus layer alteration was, thus, in relation with epithelial barrier impairment and visceral hypersensitivity. L. farciminis administration prevented WAS-induced functional, biochemical and physical changes of mucus. The presence of L. farciminis in the ileum and colon was detected by FISH and qPCR, albeit with quantitative and qualitative differences in the colonization capacity within these two intestinal compartments. Furthermore, the presence of Segmented Filamentous Bacteria (SFB) was shown in the ileum whatever the conditions under study. L. farciminis reduced the SFB population level in both control and stressed animals.Conclusion. Chronic stress induced functional changes (intestinal hyperpermeability and visceral hypersensitivity) in rats, as well as a shift in mucin O-glycosylation rather than changes in mucin expression. Intestinal mucin O-glycan modifications resulted in a loss of mucus layer cohesive properties. L. farciminis treatment prevented impairment of both intestinal epithelial and mucus barriers, reflecting an enhancement of the protective barrier function. These results confirm that L. farciminis is a valuable probiotic in the IBS management.
|
86 |
Gastrointestinal mucosal protective mechanisms : Mudolatory effects of Heliobacter pyroli on the gastric mucus gel barrier and mucosal blood flow in vivoAtuma, Christer January 2000 (has links)
<p>The gastrointestinal mucus gel layer and blood flow are two important mechanisms for protection at the pre-epithelial and sub-epithelial levels, respectively. <i>Helicobacter pylori</i> might circumvent these mechanisms and elicit a chronic inflammatory response with consequent ulcers in the stomach and duodenum. In this thesis, the physical state and properties of the adherent mucus gel layer was studied from the stomach to colon. Furthermore, the acute and chronic effects of <i>H. pylori</i> on the integrity of the mucus gel layer and mucosal blood flow were studied in the anesthetized rat.</p><p>A translucent mucus gel covers all studied segments of the gastrointestinal tract during fasting conditions, with the thickest layers in the colon and ileum. Carefully applied suction revealed that the mucus gel was a multi-layered structure comprising a firmly adherent layer covering the mucosa, impossible to remove, and a loosely adherent upper layer. The firmly adherent layer was thick and continuous in the corpus (80μm), antrum (154μm) and colon (116μm), but thin (<20μm) and discontinuous in the small intestine.</p><p>Following mucus removal, a rapid renewal of the loosely adherent layer ensued. The highest rate was observed in the colon with intermediate values in the small intestine. Mucus renewal in the stomach was attenuated on acute luminal application of water extracts from <i>H. pylori</i> (HPE). In animals with a chronic <i>H. pylori</i> infection the mucus renewal rate was unaffected, but the total gastric mucus gel thickness was reduced and the mucus secretory response to luminal acid (pH1) attenuated in the antrum. </p><p>HPE from type I strains acutely reduced corporal mucosal blood flow, measured with laser-Doppler flowmetry, by approximately 15%. The reduction in blood flow was mediated by a heat stable factor other than VacA and CagA. Inhibition of endogenous nitric oxide production with Nω-nitro-l-arginine augmented the decrease. However, ketotifen, a mast cell stabilizer, completely attenuated the effect of the extract as did the platelet activating factor (PAF) receptor-antagonist, WEB2086, thus depicting a detrimental role for the microvascular actions of PAF.</p>
|
87 |
<i>Helicobacter pylori</i> and Gastric Protection Mechanisms : An <i>in vivo</i> Study in Mice and RatsHenriksnäs, Johanna January 2005 (has links)
<p>The stomach is frequently exposed to hazardous agents and to resist this harsh environment, several protective mechanisms exist. Of special interest is the gastric pathogen <i>Helicobacter pylori </i>which causes gastritis, ulcers and cancer but the mechanism leading to these diseases are still unclear. However it is very likely that <i>H. pylori </i>negatively influence the protection mechanisms that exist in the stomach. </p><p>The aims of the present investigation were first to develop an in vivo mouse model in which different protection mechanisms could be studied, and second to investigate the influence of <i>H. pylori</i> on these mechanisms. </p><p>An in vivo preparation of the gastric mucosa in mice was developed. This preparation allows studies of different gastric mucosal variables and can also be applied for studies in other gastro-intestinal organs. </p><p>Mice chronically infected with <i>H. pylori</i>, were shown to have a reduced ability of the mucosa to maintain a neutral pH at the epithelial cell surface. This could be due to the thinner inner, firmly adherent mucus gel layer, and/or to defective bicarbonate transport across the epithelium. The Cl<sup>-</sup>/HCO<sub>3</sub><sup>-</sup> exchanger SLC26A9 was inhibited by NH<sub>4</sub><sup>+</sup>, which also is produced by <i>H. pylori</i>. The mRNA levels of SLC26A9 were upregulated in infected mice, suggesting a way to overcome the inhibition of the transporter. Furthermore, the hyperemic response to acid pH 2 and 1.5 was abolished in these mice. The mechanisms by which the bacteria could alter the blood flow response might involve inhibition of the epithelial iNOS.</p><p>Water extracts of <i>H. pylori </i>(HPE) reduces the blood flow acutely through an iNOS and nerve-mediated pathway, possibly through the endogenous iNOS inhibitor ADMA. Furthermore, HPE alters the blood flow response to acid as the hyperemic response to acid pH 0.8 is accentuated in mice treated with HPE. </p>
|
88 |
Gastrointestinal mucosal protective mechanisms : Mudolatory effects of Heliobacter pyroli on the gastric mucus gel barrier and mucosal blood flow in vivoAtuma, Christer January 2000 (has links)
The gastrointestinal mucus gel layer and blood flow are two important mechanisms for protection at the pre-epithelial and sub-epithelial levels, respectively. Helicobacter pylori might circumvent these mechanisms and elicit a chronic inflammatory response with consequent ulcers in the stomach and duodenum. In this thesis, the physical state and properties of the adherent mucus gel layer was studied from the stomach to colon. Furthermore, the acute and chronic effects of H. pylori on the integrity of the mucus gel layer and mucosal blood flow were studied in the anesthetized rat. A translucent mucus gel covers all studied segments of the gastrointestinal tract during fasting conditions, with the thickest layers in the colon and ileum. Carefully applied suction revealed that the mucus gel was a multi-layered structure comprising a firmly adherent layer covering the mucosa, impossible to remove, and a loosely adherent upper layer. The firmly adherent layer was thick and continuous in the corpus (80μm), antrum (154μm) and colon (116μm), but thin (<20μm) and discontinuous in the small intestine. Following mucus removal, a rapid renewal of the loosely adherent layer ensued. The highest rate was observed in the colon with intermediate values in the small intestine. Mucus renewal in the stomach was attenuated on acute luminal application of water extracts from H. pylori (HPE). In animals with a chronic H. pylori infection the mucus renewal rate was unaffected, but the total gastric mucus gel thickness was reduced and the mucus secretory response to luminal acid (pH1) attenuated in the antrum. HPE from type I strains acutely reduced corporal mucosal blood flow, measured with laser-Doppler flowmetry, by approximately 15%. The reduction in blood flow was mediated by a heat stable factor other than VacA and CagA. Inhibition of endogenous nitric oxide production with Nω-nitro-l-arginine augmented the decrease. However, ketotifen, a mast cell stabilizer, completely attenuated the effect of the extract as did the platelet activating factor (PAF) receptor-antagonist, WEB2086, thus depicting a detrimental role for the microvascular actions of PAF.
|
89 |
Helicobacter pylori and Gastric Protection Mechanisms : An in vivo Study in Mice and RatsHenriksnäs, Johanna January 2005 (has links)
The stomach is frequently exposed to hazardous agents and to resist this harsh environment, several protective mechanisms exist. Of special interest is the gastric pathogen Helicobacter pylori which causes gastritis, ulcers and cancer but the mechanism leading to these diseases are still unclear. However it is very likely that H. pylori negatively influence the protection mechanisms that exist in the stomach. The aims of the present investigation were first to develop an in vivo mouse model in which different protection mechanisms could be studied, and second to investigate the influence of H. pylori on these mechanisms. An in vivo preparation of the gastric mucosa in mice was developed. This preparation allows studies of different gastric mucosal variables and can also be applied for studies in other gastro-intestinal organs. Mice chronically infected with H. pylori, were shown to have a reduced ability of the mucosa to maintain a neutral pH at the epithelial cell surface. This could be due to the thinner inner, firmly adherent mucus gel layer, and/or to defective bicarbonate transport across the epithelium. The Cl-/HCO3- exchanger SLC26A9 was inhibited by NH4+, which also is produced by H. pylori. The mRNA levels of SLC26A9 were upregulated in infected mice, suggesting a way to overcome the inhibition of the transporter. Furthermore, the hyperemic response to acid pH 2 and 1.5 was abolished in these mice. The mechanisms by which the bacteria could alter the blood flow response might involve inhibition of the epithelial iNOS. Water extracts of H. pylori (HPE) reduces the blood flow acutely through an iNOS and nerve-mediated pathway, possibly through the endogenous iNOS inhibitor ADMA. Furthermore, HPE alters the blood flow response to acid as the hyperemic response to acid pH 0.8 is accentuated in mice treated with HPE.
|
90 |
Modification de la biodisponibilité orale des médicaments : interactions « Herb-Drugs » « Drugs- Drugs». / Modification of oral Bioavailability of drugs : interactions " herb drugs and drugs-drugs ".Dossou-Yovo, Flore 31 January 2014 (has links)
L’administration par voie orale des médicaments reste encore de nos jours la voie royale de la prise des médicaments car moins onéreuse et plus adaptée au confort du patient. Mais cette voie reste toujours inaccessible pour certains médicaments comme les médicaments biologiques et les bio similaires voir certains anticancéreux et antirétroviraux.Le but de ce travail est d’améliorer la biodisponibilité par voie orale des médicaments à faible biodisponibilité par la mise au point d’un promoteur d’absorption. Pour y arriver nous avons adopté comme stratégie de développer un promoteur qui agit à la fois sur le passage passif et sur le passage actif des médicaments. Les études in vitro ont été réalisées en chambre de perméation d’Ussing adaptées par la société Biomécatronics SAS (BéthuneFrance). Dans la première partie de ce travail (Brevet), nous avons montré que l’utilisation d’une composition pharmaceutique et/ou diététique comprenant un extrait de plante(Hibiscus sabdariffa) pouvait augmenter la biodisponibilité in vitro des médicaments et des xénobiotiques qui passent par la voie paracellulaire comme le cisplatine (21 fois),l’oxaliplatine (11fois), la fluorescéine isothiocyanate-Dextran 4000 (3 fois), mais également les médicaments connus pour leur transport actif par la voie transcellulaire comme l’Efavirenz (7 fois) et l’Atazanavir (4 fois). Dans la seconde partie de ce travail, nous avons cherché à vérifier si notre promoteur d’absorption des médicaments a un effet sur la couche de mucus intestinale.Cette couche peut être un facteur limitant de passage des médicaments au travers de la barrière intestinale.Dans un premier temps (article 1), nous avons induit l’augmentation de la couche mucus au niveau du colon de rat après un prétraitement pendant une semaine avec le métronidazole. Puis nous avions confirmé (article 2) que l’administration par voie orale de deux antibiotiques le Cotrimoxazole (CTX) et le métronidazole (MTZ) pendant une semaine augmente la couche de mucus au niveau du côlon ; aussi nous avons montré qu’il existe une relation entre l’augmentation de la couche de mucus et la diminution de la conductance qui est l’index de transport passif des ions, des électrolytes et de certaines molécules à faibles poids moléculaires.De plus l’augmentation de la couche de mucus au niveau de l’intestin est responsable de la diminution du passage transépithélial des deux antirétroviraux dont l’utilisation est recommandée en première ligne par l’OMS (le.Ritonavir et l’Atazanavir) surles sujets porteurs du VIH (virus de l’immunodéficience humain). Après les traitements auMTZ et au CTX la sécrétion de l’Atazanavir augmente respectivement dans le côlon proximal de 2 et 4 fois et dans le côlon distal de 3 et 5 fois. On obtient également une sécrétion du Ritonavir de 5 et 10 fois dans le proximal et de 2 et 5 fois plus dans le distal.Le travail se poursuit par l’étude de l’effet de notre promoteur d’absorption des médicaments sur la couche de mucus intestinal.En conclusion, ce travail montre que l’on peut augmenter la biodisponibilité in vitroen utilisant les promoteurs de l’absorption des xénobiotiques qui agissent à la fois au niveau du transport passif et actif. / Oral dosing is still seen as the silver bullet of drug administration, as it is cheaper andbetter adapted to patient comfort. However, oral route is still inaccessible to many drugssuch as biologics and biosimilars respectively certain anticancer drugs and antiretrovirals(ARV).The aim of this present study was to find new drugs enhancers that improve the oralbioavailability of drugs and xenobiotics. All the studies were realized in vitro using Ussingchambers technic. To achieve the set objective we used the strategy to develop drugenhancer which can modulate at the same time transcellular and paracellular pathways.In the first part of this study (patent) we have shown that the use of a pharmaceutical and /or a dietetic formulation containing a plant extract (Hibiscus sabdariffa) could increase thebioavailability in vitro in rats not only of cisplatin (21 fold), oxaliplatin (11 fold) andFluorescein Isothiocyanate-Dextran 4000 (FD4, 3 fold). All that drugs were transportedthrough intestinal barrier using paracellular pathway. In addition the study showed thatthis formulated enhancer can increased the bioavailability of Efavirenz (7 fold) andAtazanavir (4 fold) which are active transported.In order to assess the effect of new drugs enhancer on mucus thickness that limits thetransport of xenobiotic through intestinal barrier, we decide to evaluate his effect on passiveand active transport of drugs.In the second part of this study we have shown that after a week of pre-treatment of ratswith Metronidazole (MTZ, publication 1) and Cotrimoxazole (CTX, publication 2), the twomost commonly used antibiotics in the prophylaxis against opportunistic infections in HIV /AIDS, both increase colonic mucus thickness that affect directly passive intestinalpermeability by reducing conductance an index of passive transport through intestinalepithelium. In addition those antibiotics also entail a change in the transepithelialconductance and ARV fluxes. After MTZ and CTX treatment the secretion of Atazanavir(ATZ) increases respectively in the proximal colon by 2 to 4 fold and in the distal colon by 3to 5 fold respectively. Ritonavir (RTV) is poorly absorbed in control, after a week of pretreatmentwith MTZ and CTX one rather notices a secretion of RTV 5 to 10 fold higher in theproximal and 2 to 5 fold higher in the distal colon. The next study will be conducted toevaluate the effect of new drugs enhancer on mucus thickness layer.In conclusion, oral bioavailability of drugs and xenobiotics can be enhanced bypharmaceutical composition that contains herbal extract which increase passive and activetransport of drugs through intestinal barrier.
|
Page generated in 0.0491 seconds